🌅 Today's Morning Call
|
S&P Futures
7,177.75
▲ +21.00 (+0.29%)
|
Nasdaq Futures
26,879.75
▲ +68.00 (+0.25%)
|
Dow Futures
49,933.00
▲ +238.00 (+0.48%)
|
|
10Y Treasury
4.25%
▲ +0.00%
|
US Dollar
98.20
▲ +0.06 (+0.06%)
|
Bitcoin
$76,449
▲ +$574 (+0.76%)
|
Data as of 8:08 AM ET
Good morning! Futures are pointing to a solid open this Tuesday as corporate earnings continue to impress. Healthcare and industrial names are leading the charge in pre-market action, with Quest Diagnostics, Danaher, and UnitedHealth all posting better-than-expected first quarter results. Here's what's moving markets this morning.
👀 What to Watch Today
The earnings parade continues today with several notable reports hitting the tape. Healthcare is taking center stage after Quest Diagnostics (DGX) raised its full-year outlook on strong testing demand, while Danaher (DHR) beat profit estimates thanks to robust bioprocessing tool sales. UnitedHealth (UNH) also delivered a turnaround quarter, boosting its annual forecast and announcing company changes that have investors nodding in approval.On the industrial side, GE Aerospace (GE) surpassed profit expectations with its commercial engines business firing on all cylinders, pushing the stock into positive territory for 2026. Halliburton (HAL) reported rising Q1 profits driven by Latin American and European demand, offsetting weakness in the Middle East. The question now is whether this earnings strength can push major indices to fresh highs.
Not all news is rosy, though. Merck (MRK) and Eisai face a setback after their experimental cancer drug combination missed key objectives in a late-stage kidney cancer study. Meanwhile, AB InBev (BUD) is battling India's antitrust agency in what's becoming a messy legal situation despite years of cooperation.
🌏 Overnight Recap
Asian markets traded mixed overnight as investors digested China's latest economic data and positioned ahead of more corporate earnings. Japan's Nikkei edged higher while Hong Kong's Hang Seng drifted lower on continued concerns about property sector weakness. European markets opened modestly higher, with the Stoxx 600 catching a bid on energy and healthcare strength.The dollar index is ticking up to 98.20, gaining six basis points as Treasury yields hold relatively steady. The 10-year is parked at 4.25%, unchanged from yesterday's close, while the 30-year sits at 4.88%. Bitcoin is showing some life, climbing 0.76% to $76,449 as crypto traders watch for signs of institutional buying resuming after last week's softness.
Commodity markets are quiet, with crude oil holding near recent levels and gold treading water around key support. The overnight action suggests investors are waiting for today's U.S. session to provide direction, with earnings and any Fed commentary likely to set the tone.
Sponsored Content
Is Gold About to Replace the Dollar as the World's Reserve Currency?
Central banks are hoarding gold and dumping the dollar - and one little-known fund is paying out up to 64% a year while the metal climbs. An income expert calls it "the smartest gold play most investors have never heard of."
📊 Pre-Market Movers
Danaher (DHR) is up 2% in pre-market trading after crushing Q1 profit estimates on the back of strong bioprocessing demand. The life sciences giant is benefiting from pharmaceutical manufacturers ramping up production capacity, and that tailwind shows no signs of slowing. Quest Diagnostics (DGX) is also catching a bid after raising its 2026 revenue and profit outlook, signaling that diagnostic testing demand remains resilient.GE Aerospace (GE) shares are climbing after the industrial stalwart beat profit expectations, with its commercial engines business delivering ahead of forecasts. The stock is now positive for the year, a notable turnaround from its sluggish start to 2026. UnitedHealth (UNH) is adding to gains after announcing improved full-year guidance alongside some organizational changes that analysts are viewing positively.
On the downside, Merck (MRK) is under pressure after disclosing that its experimental cancer treatment combo with Eisai missed primary endpoints in a late-stage kidney cancer trial. It's a setback for the pharma giant's oncology pipeline and raises questions about near-term growth drivers beyond Keytruda.
🔍 Today's Watchlist
- Healthcare earnings momentum - DGX, DHR, UNH all beating expectations
- GE Aerospace profit surge - commercial engines driving the beat
- Merck cancer drug setback - late-stage study misses key targets
- Trump tariff stance - Trade Rep says Mexican tariffs staying put
- JPMorgan Europe expansion - $1.5T economic security program goes continental
Sponsored Content
Middle East Conflict Lights Fuse on US Debt Bomb
America was already drowning in $38 trillion of debt, but the recent conflict in the Middle East just accelerated the timeline. As oil spikes, a 100-year-old stock market signal that accurately predicted the 2008 and 2020 crashes is flashing a massive "Sell" on dozens of popular U.S. equities. If you hold the wrong stocks when this debt crisis hits, it could wipe out years of gains.
🎯 The Morning Playbook
The setup for Tuesday looks constructive, with futures higher across the board and earnings quality holding up nicely. Healthcare is proving to be a bright spot, with diagnostics, bioprocessing, and managed care all showing strength. That sector rotation into defensive growth could provide support if tech takes a breather or if macro concerns resurface.Keep an eye on the industrial names like GE and Halliburton. Their results suggest global demand isn't falling off a cliff, even with pockets of weakness in certain regions. If commodity prices stabilize and the dollar doesn't run too hot, these stocks could have more room to run. The ongoing tariff rhetoric from the Trade Rep is worth monitoring, especially for auto and steel names with Mexican exposure.
Bottom line: Let earnings be your guide today. The companies executing well are getting rewarded, while those stumbling are facing swift punishment. Stay selective, focus on quality, and don't chase moves that have already run. It's a stock picker's market, and that's exactly where patient investors can find opportunity.